【24h】

Branched grafting for aortoiliac aneurysms.

机译:分枝移植用于主动脉瘤。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To evaluate a novel approach to preserve pelvic perfusion during endovascular AAA repair in patients with common iliac aneurysms extending to the iliac bifurcation. MATERIALS AND METHODS: A multicenter prospective analysis of patients undergoing implantation of a branched endograft designed to perfuse the internal iliac artery was conducted. All patients enrolled were considered high risk for open surgical repair and presented with common iliac artery aneurysms greater than 20mm and anatomy amenable to implant the branched device. Preoperative high resolution spiral CT, and follow-up CT studies in addition to abdominal radiographs were obtained at discharge, 1, 6, 12, and 24 months. RESULTS: Between 2003 and 2006, 52 patients (53 internal iliacs) were implanted with an investigational device. Mean common iliac aneurysm maximal diameter was 38mm. The branch graft was combined with a proximal standard bifurcated component (61%), a fenestrated or a visceral branch component (33%), an aortouni-iliac component (2%), and alone in 2 patients (4%, following prior aortobi-iliac repair). Technical success was achieved in 94% of patients. Within the first month, 6 (11%) internal iliac branches occluded. No occlusions were noted after 1 month. The mean follow-up was 14.2 months. Common iliac aneurysm shrinkage was noted in 42% and 81% of patients at 6 and 12 months. There were no rupture, aneurysm related deaths or conversions, but there were 7 deaths during follow-up. CONCLUSIONS: The placement of endovascular prostheses that maintain antegrade perfusion of one or both internal iliac arteries is feasible, and early results provide evidence for optimism with regard to safety and efficacy.
机译:目的:评估一种在approach内动脉瘤延伸至分叉的患者中进行血管内AAA修复期间保持盆腔灌注的新方法。材料与方法:对接受植入灌注内动脉的分支内移植物的患者进行了多中心前瞻性分析。所有入组患者均被认为是开放手术修复的高风险患者,并表现为common大动脉瘤大于20mm且解剖结构适合植入分支装置。在出院后第1、6、12和24个月进行了术前高分辨率螺旋CT和腹部X线摄影的后续CT研究。结果:在2003年至2006年之间,有52例患者(53个internal内)被植入了研究装置。平均common总动脉瘤最大直径为38mm。分支移植物与近端标准分叉组件(61%),有窗或内脏分支组件(33%),主动脉uni-组件(2%)合并,在2例患者中(4%,在先有主动脉之后) -ilia修复)。 94%的患者获得了技术成功。在第一个月内,有6个(11%)内分支被阻塞。 1个月后未见阻塞。平均随访14.2个月。在6个月和12个月时,分别有42%和81%的患者发现了常见的动脉瘤缩小。没有破裂,与动脉瘤相关的死亡或转换,但在随访期间有7例死亡。结论:放置能够维持一或两个internal内动脉顺行灌注的血管内假体是可行的,早期结果为安全性和有效性方面的乐观提供了证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号